Retroperitoneoscopic Microwave Ablation of Renal Hamartoma:Middle-term Results
10.1007/s11596-010-0562-x
- Author:
GUAN WEI
1
;
BAI JIAN
;
HU ZHIQUAN
;
SU YAOWU
;
ZHUANG QIANYUAN
;
YE ZHANGQUN
Author Information
1. Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China
- Keywords:
retroperitoneoscope;
renal hamartoma;
microwave ablation
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2010;30(5):669-671
- CountryChina
- Language:Chinese
-
Abstract:
The safety and efficacy of retroperitoneoscopic microwave ablation (MWA) in the treatment of renal hamartoma were evaluated. From July 2007 to July 2009, a total of 16 cases of renal hamartoma were treated with retroperitoneoscopic MWA. Peri- and post-operative findings were observed. Middle-term efficacy was assessed by contrast-enhanced computerized tomography (CT) in follow-up period. All patients received MWA of 1-5 points. The mean operative time was 85 min and the mean blood loss was 65 mL. During a median follow-up of 16 months, no evidence of disease recurrence was observed despite of incomplete ablation in 1 case. Retroperitoneoscopic MWA is a relatively simple procedure with less impact to renal function and less complication. The outcome of middle-term follow-up is satisfactory. Thus, retroperitoneoscopic MWA appears to be a safe and effective technique for renal hamartoma in selected patients.
